Aspire Health Science

Executive Summary

Aspire Health Science is a contract development and manufacturing organization (CDMO) headquartered in Miami, Florida, with an FDA-registered, cGMP-compliant facility in Orlando. Specializing in cellular and regenerative therapies, the company provides end-to-end services from process development through commercial manufacturing. As a member of the HealthBanks Group, Aspire aims to make advanced therapies more accessible by offering high-quality, scalable manufacturing solutions. Founded in 2017, the company operates in the rapidly growing cell and gene therapy CDMO market, capitalizing on increasing demand for outsourced manufacturing expertise. Its Orlando facility positions it to serve a broad range of clients, from small biotechs to larger pharmaceutical companies, seeking to bring cell-based treatments to market. While financial details remain private, Aspire's strategic focus on regenerative medicine and its cGMP capabilities position it as a key player in the space.

Upcoming Catalysts (preview)

• Q3 2026Facility Expansion Announcement70% success
• Q4 2026Major Client Contract Win60% success
• H1 2027FDA Approval for Client Therapy Manufactured by Aspire50% success